Market Cap 42.36M
Revenue (ttm) 40.50M
Net Income (ttm) -69.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -170.84%
Debt to Equity Ratio -2.47
Volume 2,538,700
Avg Vol 4,554,170
Day's Range N/A - N/A
Shares Out 124.63M
Stochastic %K 3%
Beta 1.68
Analysts Strong Sell
Price Target $5.00

Latest News on MRSN

Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 12:55 PM EDT - 8 months ago

Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript


Mersana Therapeutics Announces Changes in Leadership

Sep 6, 2023, 7:00 AM EDT - 1 year ago

Mersana Therapeutics Announces Changes in Leadership


Mersana Therapeutics Provides Statement About SVB

Mar 10, 2023, 7:10 PM EST - 2 years ago

Mersana Therapeutics Provides Statement About SVB